Banner Fairtec GmbH We Optimise the ROI of Your Event 600x60px
Collaboration › Details

Danaher–Epitomics: RabMab technology, 201202– collab supply long-term rabbit MAbs for automated ICH staining systems of Leica Biosystems


Period Period 2012-02-29
Organisations Partner, 1st Leica Biosystems (biosystems division of Leica Microsystems)
  Group Danaher (Group)
  Partner, 2nd Epitomics Inc.
  Group Abcam (Group)
Products Product RabMab® technology
  Product 2 staining system

Epitomics, Inc.. (2/29/12). "Press Release: Leica Microsystems and Epitomics Enter Agreement for Supply of Proprietary Rabbit Monoclonal Antibodies". Newcastle upon Tyne.

Leica Microsystems and Epitomics, Inc. announced today that they had reached an agreement for the supply of proprietary rabbit monoclonal antibodies to Leica Microsystems, based on Epitomics, RabMAb® technology. The agreement also provides long-term support for Leica's incorporation of Epitomics' products into higher regulatory classifications of IVD products.

"We are very pleased to enter into this strategic relationship with Epitomics" comments Dr. Konstantin Fiedler, Vice President of Advanced Staining for Leica's Biosystems Division. "In December we released the first one-step double staining detection system, Leica ChromoPlex 1™ Dual Detection for BOND. Our agreement with Epitomics will allow us to build a supporting range of antibody cocktails based of the leading Novocastra™ mouse monoclonal antibodies and Epitomics RabMAb® rabbit monoclonal antibodies. Additionally, with a selection of Epitomics' rabbit monoclonal antibodies we will also be able to further strengthen our portfolio of Novocastra concentrated and Bond Ready-to-Use antibody selection for our BOND instruments."

"We are very pleased to see our RabMabs are incorporated into one of the most advanced automated immunohistochemistry (IHC) staining systems for pathology laboratories in the world. This agreement is another important endorsement of the quality of Epitomics products in the rapidly growing field of IHC for anatomic pathology. Epitomics has accumulated a collection of candidate antibodies for potential future incorporation into companion diagnostics products in recent years. This strategic relationship will take us to the next level." says Dr. Guo-Liang Yu, President and CEO of Epitomics Inc.

Record changed: 2015-08-01


Picture B3C Group GmbH First Biotech Pharma Medtech Diagnostics Newswire 600x60

More documents for Danaher (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture B3C Group GmbH First Biotech Pharma Medtech Diagnostics Newswire 600x60

» top


Picture EBD Group Biotech Showcase 2016 BTS San Francisco January 120x180px Picture BioM Munich Biomarker Conference 2015 München Germany December 120x180px Picture Fuse GmbH Medical App Award 2016 Life Science Nord 120x180px Picture B3C Group GmbH First Biotech Pharma Medtech Diagnostics Newswire 120x180 Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Banner [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px